Cumberland Pharmaceuticals Inc. Inventory, Raw Materials, Net of Reserves
Cumberland Pharmaceuticals Inc. (CPIX) had Inventory, Raw Materials, Net of Reserves of $9.83 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2026-03-09
- 2025-12-31: Inventory, Raw Materials, Net of Reserves $9.83M.
- 2024-12-31: Inventory, Raw Materials, Net of Reserves $11.98M.
- 2023-12-31: Inventory, Raw Materials, Net of Reserves $12.62M.
- 2023-09-30: Inventory, Raw Materials, Net of Reserves $12.05M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2025-12-31 | $9.83M 10-K · filed 2026-03-09 |
| 2024-12-31 | $11.98M 10-K · filed 2026-03-09 |
| 2023-12-31 | $12.62M 10-K · filed 2025-03-07 |
| 2023-09-30 | $12.05M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $12.86M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $12.55M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $12.90M 10-K · filed 2024-03-13 |
| 2022-09-30 | $11.74M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $12.77M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $12.37M 10-K · filed 2023-03-13 |
| 2021-09-30 | $13.78M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $14.16M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $14.76M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $16.22M 10-K · filed 2022-03-11 |
| 2020-09-30 | $17.06M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $19.66M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $19.46M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $19.35M 10-K · filed 2021-03-12 |
| 2019-09-30 | $19.18M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $19.08M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $18.38M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $18.38M 8-K · filed 2020-12-10 |
| 2018-09-30 | $2.51M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.59M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.64M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $3.16M 10-K · filed 2019-03-12 |
| 2017-09-30 | $3.19M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.98M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.48M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.81M 10-K · filed 2018-03-09 |
| 2016-09-30 | $2.62M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $3.21M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $2.40M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $2.58M 10-K · filed 2017-03-13 |
| 2015-09-30 | $2.28M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $2.74M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $2.48M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.57M 10-K · filed 2016-03-14 |
| 2014-09-30 | $2.65M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.77M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $2.78M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.03M 10-K · filed 2015-03-09 |
| 2013-09-30 | $1.12M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $1.35M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.42M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $1.31M 10-K · filed 2014-03-11 |
| 2012-09-30 | $1.84M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $1.75M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $774.64K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |